We are happy to jointly lead Genalyte’s last financing with Verily (Alphabet subsidiary) with the participation of Redmile Group, Provenio Capital, HBM Healthcare Investments, Khosla Ventures, Samsara BioCapital, and The Invus Group.

Article by

Article Date

Filtricine, Inc. is developing a proprietary targeted medical food technology to help cancer patients manage their diseases.

Delfina Care uses a patient-centered and data-driven approach to empower moms and their caregivers to have healthier babies.

Related posts